- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06718712
Resistance Exercise Volume and Hypertrophic Response Variability in Elderly
December 5, 2024 updated by: Hamilton Augusto Roschel da Silva, University of Sao Paulo General Hospital
Effects of Resistance Exercise Volume on the Variability of the Hypertrophic Response in Elderly
The study aimed to investigate the effects of resistance training volume manipulation on whole muscle hypertrophy among non-responders and responders to a low resistance training dose (single-set).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The magnitude of muscle hypertrophy in response to resistance training (RT) is highly variable between individuals (response heterogeneity).
Manipulations in RT variables may modulate RT-related response heterogeneity; yet, this remains to be determined.
Study Type
Interventional
Enrollment (Actual)
102
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
SP
-
Sao Paulo, SP, Brazil, 05508-030
- University of Sao Paulo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 60 years and older
- not engaged in regular resistance and/or aerobic training for at least six months before the intervention
Exclusion Criteria:
- diagnosed type I diabetes mellitus
- arrhythmia
- noncontrolled hypertension
- any major orthopedic musculoskeletal condition
- use of any dietary supplement or drug with potential anabolic effects
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Single set
One set of unilateral knee-extension exercise of 8-15 RM with a 60-90 s interval.
|
The RT protocol was performed using a unilateral knee-extension machine.
To reduce potential sources of bias to exercise order, subjects alternated the starting leg for each training session.
|
|
Experimental: Four sets
Four sets of unilateral knee-extension exercise of 8-15 RM with a 60-90 s interval between sets.
|
The RT protocol was performed using a unilateral knee-extension machine.
To reduce potential sources of bias to exercise order, subjects alternated the starting leg for each training session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quadriceps muscle cross-sectional area
Time Frame: 10 weeks
|
Quadriceps muscle CSA was obtained through magnetic resonance imaging.
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximum dynamic strength
Time Frame: 10 weeks
|
Unilateral quadriceps 1-RM of both legs were assessed on a knee-extension machine
|
10 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dietary assessment
Time Frame: Before intervention
|
Dietary assemment using the USDA Automated Multiple-Pass Method
|
Before intervention
|
|
Mass spectrometry
Time Frame: 10 weeks
|
Mass spectrometry metabolomics
|
10 weeks
|
|
Skeletal muscle RNA-sequencing
Time Frame: 10 weeks
|
RNA sequencing using an Illumina NovaSeq Platform with a standard paired-end 150 bp (PE150) dual indexing protocol
|
10 weeks
|
|
Muscle protein measures
Time Frame: 10 weeks
|
Upstream binding factor (UBF) muscle protein was quantified by Simple Western capillary immunoassay.
|
10 weeks
|
|
Muscle protein measures
Time Frame: 10 weeks
|
v-Myc Avian Myelocytomatosis Viral Oncogene Homolog (c-Myc) muscle protein was quantified by Simple Western capillary immunoassay.
|
10 weeks
|
|
Muscle protein measures
Time Frame: 10 weeks
|
Frizzled class receptor 1 (Frizzled-1) muscle protein was quantified by Simple Western capillary immunoassay.
|
10 weeks
|
|
Muscle protein measures
Time Frame: 10 weeks
|
ribosomal protein L3 (rpL3) muscle protein was quantified by Simple Western capillary immunoassay.
|
10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2018
Primary Completion (Actual)
December 20, 2018
Study Completion (Actual)
December 20, 2018
Study Registration Dates
First Submitted
December 1, 2024
First Submitted That Met QC Criteria
December 1, 2024
First Posted (Actual)
December 5, 2024
Study Record Updates
Last Update Posted (Estimated)
December 11, 2024
Last Update Submitted That Met QC Criteria
December 5, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 62590416.0.0000.5391
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Florida Institute for Human and Machine CognitionNot yet recruitingAging | Healthy Aging | Aging WellUnited States
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
University of CopenhagenRecruitingAging | Healthy Aging | Aging FrailtyDenmark
-
Radboud University Medical CenterTerminated
-
Northwestern UniversityPotocsnak Human Longevity LabRecruitingAging | Aging Well | Aging, Biological | Aging, HealthyUnited States
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAging | Aging, HealthyFrance
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAging | Aging Disorder | Aging, HealthyFrance
-
Synbiotic HealthMusB ResearchRecruitingHealthy Aging | Anti AgingUnited States
-
Research Centre for Natural SciencesSemmelweis University; HUN-REN Institute of Experimental MedicineActive, not recruitingHealthy Aging | Neurocognitive AgingHungary
Clinical Trials on Lower body resistance training
-
Arya HabibiCompletedOverweight (BMI > 25) | Obesity (BMI>30)Iran
-
Seoul National UniversityCompletedArteriosclerosis | Body Composition | Sarcopenia | Muscle Function | Postmenopausal Women | Arterial Stiffness, Blood PressureSouth Korea
-
Loughborough UniversityVersus ArthritisActive, not recruitingOsteoarthritis | OsteoporosisUnited Kingdom
-
University of Central FloridaCompletedHealthyUnited States
-
Riphah International UniversityRecruitingSports Physical TherapyPakistan
-
University of British ColumbiaCompletedSkeletal Muscle HypertrophyCanada
-
McMaster UniversityCanadian Frailty NetworkCompleted
-
Sport and Spine Rehab Clinical Research FoundationCompletedLow Back PainUnited States
-
University Hospital, GhentAgentschap voor Innovatie door Wetenschap en TechnologieCompletedRespiratory CancerBelgium
-
Universidade Federal do Triangulo MineiroUnknownPostmenopause | Breast Cancer SurvivorsBrazil